MedPath

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States
Ownership
-
Established
1943-01-01
Employees
8.1K
Market Cap
-
Website
http://www.utsouthwestern.edu

Ramelteon and Citicoline for Delirium

Phase 4
Withdrawn
Conditions
Delirium
Interventions
First Posted Date
2016-07-21
Last Posted Date
2017-11-09
Lead Sponsor
University of Texas Southwestern Medical Center
Registration Number
NCT02840591
Locations
🇺🇸

The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States

Risk of Radiation-induced Cataracts Among Interventional Cardiology Staff

Withdrawn
Conditions
Cataract
Interventions
Other: Slit lamp eye examination
First Posted Date
2016-07-19
Last Posted Date
2019-01-18
Lead Sponsor
University of Texas Southwestern Medical Center
Registration Number
NCT02837562

Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging

Phase 4
Completed
Conditions
Obesity, Visceral
Interventions
Drug: [U-13C3] glycerol
Drug: Placebo (for Empagliflozin)
Drug: Empagliflozin
First Posted Date
2016-07-14
Last Posted Date
2020-01-23
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
40
Registration Number
NCT02833415
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators

Not Applicable
Completed
Conditions
Major Depressive Disorder
Asthma
Interventions
Other: Non-Interventional
First Posted Date
2016-06-22
Last Posted Date
2022-02-15
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
205
Registration Number
NCT02809677
Locations
🇺🇸

University of Texas Southwestern Medical Center Psychoneuroendocrine Research Program, Dallas, Texas, United States

Establishing Normative Data for Pupillometer Assessments in Neuro-Intensive Care

Recruiting
Conditions
Critical Illness
Neuropathy
First Posted Date
2016-06-17
Last Posted Date
2024-10-18
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
1000
Registration Number
NCT02804438
Locations
🇺🇸

Maria E Denbow, Dallas, Texas, United States

Acute Kidney Injury Genomics and Biomarkers in TAVR Study

Active, not recruiting
Conditions
Renal Insufficiency, Chronic
Arrhythmias, Cardiac
Acute Kidney Injury
Stroke
Heart Failure
Myocardial Infarction
Interventions
Procedure: Transcatheter Aortic Valve Replacement
First Posted Date
2016-06-07
Last Posted Date
2024-07-18
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
3000
Registration Number
NCT02791880
Locations
🇺🇸

William J. Clements University Hospital, Dallas, Texas, United States

🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

🇺🇸

Parkland Health & Hospital Systems, Dallas, Texas, United States

Adductor Canal Mid-thigh and Adductor Canal Distal Thigh: Is Cutaneous Sensory Blockade Similar Among Block Techniques?

Phase 4
Terminated
Conditions
Postoperative Pain
Interventions
First Posted Date
2016-06-02
Last Posted Date
2021-04-21
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
52
Registration Number
NCT02788019
Locations
🇺🇸

Zale Lipshy University Hospital, Dallas, Texas, United States

13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF

Phase 2
Completed
Conditions
Acute Liver Failure
Interventions
Drug: 13C-Methacetin
First Posted Date
2016-06-01
Last Posted Date
2020-12-22
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
76
Registration Number
NCT02786836
Locations
🇺🇸

UT Southwestern Medical Center at Dallas, Dallas, Texas, United States

🇺🇸

University of Washington Medical Center, Seattle, Washington, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

and more 8 locations

Low Level Laser Therapy With Physical Therapy for Chronic Musculoskeletal Pain

Not Applicable
Terminated
Conditions
Chronic Pain
Interventions
Device: Sham low level laser
Device: Active low level laser
First Posted Date
2016-05-27
Last Posted Date
2020-07-07
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
11
Registration Number
NCT02785432
Locations
🇺🇸

McDermott Pain Management Clinic, Dallas, Texas, United States

Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma

Phase 2
Terminated
Conditions
Metastatic Clear Cell Renal Cell Carcinoma
Interventions
Drug: Nivolumab
Radiation: SAbR
First Posted Date
2016-05-24
Last Posted Date
2022-08-08
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
7
Registration Number
NCT02781506
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath